Join our community of smart investors

Profits jump at 'challenger' consultancy Elixirr

The Aim-traded consultancy is gaining market share despite the tough economic backdrop
April 22, 2024
  • Strong start to 2024
  • But margins expected to dip this year

Elixirr International (ELIX) has reported double-digit growth, and momentum is set to continue into 2024. Revenue at the Aim-traded consultancy increased by a fifth in 2023 to £85.9mn, and adjusted Ebitda jumped by 24 per cent to £25.4mn. 

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in